ArticleBiomedical microdevices2026
Magnetically-guided, stimuli-responsive microdevices for endovascular therapy.
Article in Biomedical microdevices, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Current endovascular aneurysm treatments rely on catheter-based delivery systems, which inherently restrict access to tortuous anatomies and small-caliber vessels. To address this limitation, we introduce a tetherless microdevice platform that combines magnetic guidance with near-infrared (NIR) triggered shape-memory polymer (SMP) deployment for wireless aneurysm therapy. In this system, an external actuator magnet steers a microdevice-integrated effector magnet through anatomically realistic silicone vascular phantoms, while melanin-doped PLA structures enable precise NIR-induced shape recovery. Because NIR light penetrates biological tissue, deployment can be activated non-invasively from outside the body. The platform supports two device architectures tailored to different clinical needs: a spiral flow disruptor with a retrievable magnet for partial inflow modulation and a petalloid occluder designed for permanent sealing of narrow-neck aneurysms. Their navigation behavior was modelled using a flow-responsive, magnetically modulated stick-slip (F-MMSS) framework that captures the influence of pulsatile flow and wall interactions. Experimentally, magnetic steering was demonstrated under physiologically relevant flow rates and NIR activation achieved reliable deployment through ex vivo tissue. Particle image velocimetry and computational fluid dynamics confirmed substantial reductions in intra-aneurysmal velocity across multiple geometries. Material characterization further verified that PLA-melanin composites exhibit suitable bio and hemocompatibility for preliminary use. Together, these results establish a proof-of-concept platform for wireless navigation and remote deployment of endovascular microdevices, motivating future in vivo evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.